Saliva cortisol test for hard-to-control diabetes
Part of Hormones & metabolism clinical trials.
This study checks if a simple saliva test can find high cortisol levels in people with hard-to-control type 2 diabetes. It aims to help doctors identify if cortisol problems are making diabetes worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have type 2 diabetes that is hard to control (HbA1c between 7.5% and 11.5% and on multiple diabetes medicines).
- You have not used steroid pills or shots in the past 3 months.
- You are not pregnant or breastfeeding.
- You do not work night shifts.
- You are not allergic to dexamethasone.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates a new saliva test for measuring 1,5-anhydroglucitol, a marker that may help monitor blood sugar control in people with diabetes. Participants will provide saliva samples to see if this non-invasive test can accurately reflect glucose levels.
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
This study is building a reference range for a simple saliva test that measures cortisol, a hormone linked to stress and adrenal function. It may help diagnose conditions like Cushing's syndrome or adrenal insufficiency.
This trial studies people who have type 2 diabetes and excess body weight, looking at how high cortisol (a stress hormone) may be involved. If you qualify, you may get a study treatment designed to improve diabetes and weight-related health by targeting cortisol-related pathways.
This study checks whether certain substances in saliva can help detect gum disease in people with type 2 diabetes. It compares the levels of these substances in people with diabetes and gum disease, people with gum disease only, people with diabetes only, and healthy volunteers.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Hear when a new Hypercortisolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.